Contact

 

Prof. Dr. Dipl.-Phys. Heinz-Peter Schlemmer

Please contact:
Sarah Koch
Phone: +49 6221 42-2564

E-mail: s.koch@dkfz.de

 

 

Showing...

 

the enemie's face.

Department of Radiology

DKFZ
 
 
 

Our group/department has:

  • Demonstrated that diffusion-weighted MRI is a valid tool to assess and monitor tumor burden in multiple myeloma (Shah et al. Ann Hematol 2013)

  • Shown that whole-body MRI is capable of identifying high-risk patients among those with monoclonal gammopathy of unclear significance (Hillengass et al., Leukemia 2013).

  • Demonstrated in 4000 participants of a lung cancer screening program that low-dose CT is an effective tool for early detection of lung cancer in a curable stage <for lung cancer in smokers (Becker et al. J Cancer Res Clin Oncol 2012).

  • Proven that PET-MRI using a novel specific tracer (Ga68-PSMA) is capable of detecting local and distant disease in prostate cancer (Afshar-Oromieh et al., European Journal of Nuclear Medicine and Molecular Imaging 2013).

  • Shown that susceptibility-weighted MRI at 7 Tesla shows specific signal abnormalities that discriminate Glioblastoma from other primary or secondary brain neoplasms (Radbruch et al., European Journal of Radiology 2013).

2010 – 2013

  • Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, Schnabel PA, Pilz L, Eichinger M, Optaizaite DE, Puderbach M, Tremper J, Delorme S. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round. J Cancer Res Clin Oncol 2012 (published online)

  • Shah R, Stieltjes B, Andrulis M, Pfeiffer R, Sumkauskaite M, Delorme S, Schlemmer HP, Goldschmidt H, Landgren O, Hillengass J.
    Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases. Ann Hematol 2013 (in press)

  • Hillengass J, Weber MA, Kilk K, Listl K, Wagner-Gund B, Hillengass M, Hielscher T, Farid A, Neben K, Delorme S, Landgren O, Goldschmidt H.
    Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance. Leukemia 2013 (in press).

  • Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, Hadaschik BA, Giesel,FL, Debus J, Haberkorn U:
    Comparison of PET imaging with a 68Ga-labelled PSMA-ligand and 18F-choline based PET/CT for the diagnosis of recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 2013;40:1629-30.

  • Radbruch A, Wiestler B, Kramp L, Lutz K, Baeumer P, Weiler M, Roethke M, Sahm F, Schlemmer HP, Wick W, Heiland S, Bendszus M:
    Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. European Journal of Radiology 2013;82 (3), 552-556

  • DFG/ Dietmar Hopp-Stiftung - Lungenkrebs-Screening-Initiative (LUSI):    „Spiral CT scanning for the early detection of lung cancer; Randomized controlled screening trial of multidetector spiral CT scanning in Germany” 2008 – 2013

  • DFG - SFB 79: „Werkstoffe für die Geweberegeneration im systemisch erkrankten Knochen“. Teilprojekt B8 „Untersuchung von Knochensubstanzdefekten und Mikrozirkulation mittels Volumen-.Computertomographie und dynamischer kontrast-verstärkter Magnetresonanztomographie“. 2010– 2014

  • BMBF - DOT-MOBI: „Softwareplattform für die multimodale Diagnostik onkologischer Erkrankungen und Therapieoptimierung durch molekulare Bildgebung“. 2009 – 2011

  • Coolidge Award 2013 (Dr. Alexander Radbruch)

  • Wachsmann-Preis 2011 of the German Roentgen Society (Prof. Stefan Delorme)

  • Wollheim-Preis der Ernst und Hedda Wollheim-Stiftung zur Erforschung des Bluthochdrucks 2012 (Dr. Dr. C. H. Ziener)

  • Preis aus dem Nachlass von Klug und Sichler 2013 (Dr. Dr. C. H. Ziener)